Indeed, in our animal model study, both CSN6 KD (leading to NPM1 decrease) and the NPM1 inhibitor NSC348884 showed strong efficacy in tumor inhibition and gemcitabine sensitization. This evidence concerns the gene COPS6 and neoplasm.